The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells

Oncogene

Volumn 18, Issue 3, 1999, Pages 739-746

  Scotlandi, Katia ^a   Manara, Maria Cristina ^a   Serra, Massimo ^a   Benini, Stefania ^a   Maurici, Daniela ^a   Caputo, Antonella ^b   De Giovanni, Carla ^c   Lollini, Pier Luigi ^c   Nanni, Patrizia ^c   Picci, Piero ^a   Campanacci, Mario ^a   Baldini, Nicola ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

MDR1 gene; Metastasis; Osteosarcoma; P glycoprotein; Tumorigenicity

Indexed keywords

GLYCOPROTEIN P; MEMBRANE ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENICITY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS POTENTIAL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOSARCOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0033590603     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202330     Document Type: Article

References (31)

1. Baldini N, Scotlandi K, Barbanti-Brodano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M and Serra M. (1995). N. Engl. J. Med., 333, 1380-1385.
2. Baldini N. (1997). Nature Med., 3, 378-380.
3. Bashir I, Sikora K, Abel P and Foster CS. (1994). Int. J. Cancer, 57, 719-726.
4. Bénard J, Da Silva J, Teyssier JR and Riou G. (1989). Int. J. Cancer, 43, 471-477.
5. Biedler JL, Riehm H, Peterson RHF and Spengler BA. (1975). J. Natl. Cancer Inst., 55, 671-677.
6. Biedler JL and Spengler BA. (1994). Cancer Met. Rev., 13, 191-207.
7. Bradley G, Sharma R, Rajalakshimi S and Ling V. (1992). Cancer Res., 52, 5154-5161.
8. Bradley G and Ling V. (1994). Cancer Met. Rev., 13, 223-233, 1994.
9. Chan HSL, Thorner PS, Haddad G and Ling V. (1990). J. Clin. Oncol., 8, 689-704.
10. Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusck N, Yeger H and Ling V. (1991). N. Engl. J. Med., 323, 1608-1614.
11. Chan HSL, Grogan TM, Haddad G, DeBoer G and Ling V. (1997) J. Natl. Cancer Inst., 89, 1706-1715.
12. Chen C, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM and Roninson IB. (1986). Cell, 47, 381-389.
13. Foote SJ, Thompson JK, Cowman AF and Kemp DJ. (1989). Cell, 57, 921-930.
14. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai S, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM and Pastan I. (1989). J. Natl. Cancer inst., 81, 116-124.
15. Gottesman MM and Pastan I. (1993). Annu. Rev. Biochem., 62, 385-427.
16. Habu S, Fukuyi H, Shimamura K, Kasai M, Nagai Y, Okumura K and Tamaoki N. (1981). J. Immunol., 127, 34-38.
17. Higgins CF. (1992). Annu. Rev. Cell Biol., 8, 67-113.
18. Hoffman MM, Wei L-Y, and Roepe PD. (1996). J. Gen. Physiol., 108, 295-313.
19. Kerbel RS and MacDougall JR. (1993). Drug Resistance in Oncology. Teicher B.A. (ed.). New York: Marcel Dekker, 583-601.
20. Lincke CR, van der Bliek AM, Schuurhuis GJ, van der Velde-Koerts T, Smit JJM and Borst P. (1990). Cancer Res., 50, 1779-1785.
21. Mirski SEL, Gerlach JH and Cole SPC. (1987). Cancer Res., 47, 2594-2598.
22. Murphy LD, Herzog CE, Rudick JB, Fojo AT and Bates SE. (1990). Biochemistry, 29, 10351-10356.
23. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV and Willingham MC. (1988). Proc. Natl. Acad. Sci. USA, 85, 4486-4490.
24. Pinedo HM and Giaccone G. (1995). N. Engl. J. Med., 333, 1417-1419.
25. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS and Tsui LC. (1989). Science, 245, 1066-1073.
26. Rodan SB, Imai Y, Thiede MA, Wesolowski G, Thompson D, Bar-Shavit Z, Shull S, Mann K and Rodan GA. (1986). Caner Res., 47, 4961-4966.
27. Roepe PD, Wei LY, Hoffman MM and Fritz F. (1996). J. Bioenerg. Biomembr., 28, 541-555.
28. Scotlandi K, Serra M, Nicoletti G, Vaccari M, Manara MC, Nini G, Landuzzi L, Colacci A, Bacci G, Bertoni F, Picci P, Campanacci M and Baldini N. (1996). Cancer Res., 56, 2434-2439.
29. Serra M, Scotlandi K, Manara MC, Maurici D, Lollini PLL, De Giovanni C, Toffoli G and Baldini N. (1993). Anticancer Res., 13, 323-330.
30. Thomas PM, Cote GJ, Wohlik N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF and Bryan J. (1995). Science, 268, 426-429.
31. Ueda K, Cardarelli C, Gottesman MM and Pastan I. (1987). Proc. Natl Acad Sci USA, 84, 3004-3008.